Curis
CRIS
#10225
Rank
HK$95.98 M
Marketcap
HK$6.99
Share price
3.93%
Change (1 day)
-69.51%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -HK$28.58

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$28.77. In 2024 the company made an earnings per share (EPS) of -HK$55.10 an increase over its 2023 EPS that were of -HK$70.78.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$28.58-48.13%
2024-HK$55.10-22.15%
2023-HK$70.78-26.17%
2022-HK$95.8622.3%
2021-HK$78.38-25.37%
2020-HK$105.03-30.93%
2019-HK$152.06-2.02%
2018-HK$155.19
2016-HK$352.71-10%
2015-HK$391.90138.1%
2014-HK$164.6040%
2013-HK$117.57-25%
2012-HK$156.7666.67%
2011-HK$94.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.66-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.28-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$18.65-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.49-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$88.10 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.05-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA